Bipartisan Lawmakers Seek To Extend Military Psychedelics Research Program Until 2033
A bipartisan group of members of Congress have filed an amendment to a large-scale military bill that would extend a psychedelics research effort at the Department of Defense (DOD) for an additional six years. Reps. Morgan Luttrell (R-TX), Jack Bergman (R-MI), Derrick Van Orden (R-WI), Mike Ezell (R-MS), Troy Carter (D-LA) and Morgan McGarvey (D-KY) […]
Anti-Marijuana Groups And Pharma Company Ask Court To Revive Lawsuit Challenging Medicare Hemp Coverage Program
A coalition of anti-marijuana groups and a cannabis-focused biopharmaceutical corporation are asking a federal appeals court to overturn a judge’s dismissal of their lawsuit challenging a new Trump administration initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. Last month, Judge Trevor N. McFadden dismissed the challenge to […]
Connecticut Governor Signs Bill To Expand Psychedelics Pilot Program In Preparation For Federal FDA Approval
Connecticut’s governor has signed a bill to expand a pilot program that’s meant to explore the therapeutic potential of psychedelics such as psilocybin and MDMA. The legislation sponsored by the Joint Committee on Public Health cleared the House of Representatives in 122-27 vote last month after passing the Senate by a unanimous 35-0 vote in […]
Amber Senter, Architect of Oakland’s Cannabis Equity Program, Says Founders Should Skip the Dispensary
Amber Senter co-founded Supernova Women, the organization that helped shape America’s first cannabis social equity program. A decade later, she says the licenses meant to repair the War on Drugs sent Black founders into the industry’s most expensive, lowest-margin, hardest-to-survive corner. “You need $2 million to open a dispensary. If you have $50,000, you can […]
Federal Judge Dismisses Anti-Marijuana Groups’ Lawsuit Challenging Medicare Hemp Coverage Program
A federal judge has granted the government’s motion to dismiss marijuana legalization opponents’ lawsuit challenging a new Trump administration initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows a certain […]